Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

<p>Demographics and Baseline Characteristics</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Cloud P. Paweletz (14960112) (author)
Autres auteurs:	Grace A. Heavey (16495683) (author), Yanan Kuang (16495686) (author), Emily Durlacher (16495689) (author), Thian Kheoh (16495692) (author), Richard C. Chao (16495695) (author), Alexander I. Spira (16495698) (author), Konstantinos Leventakos (16495701) (author), Melissa L. Johnson (16019536) (author), Sai-Hong Ignatius Ou (15023025) (author), Gregory J. Riely (14961725) (author), Kenna Anderes (15123501) (author), Wenjing Yang (16495704) (author), James G. Christensen (15123507) (author), Pasi A. Jänne (14954872) (author)
Publié:	2025
Sujets:	Cancer Clinical Research and Trials Methods and Technology Imaging Liquid Biopsy Precision Medicine
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires